Patient-dependent factors limiting guideline-directed medical therapy in patients with heart failure with reduced left ventricular ejection fraction undergoing scheduled hospitalization
Implementation of recommendations regarding pharmacotherapy optimization in patients with heart failure undergoing scheduled hospitalization - the HEROES study.
Design and rationale of a phase 3 study to evaluate the efficacy and safety of nucresiran (ALN-TTRsc04) in patients with transthyretin amyloidosis with cardiomyopathy